artificial intelligence
-
Artificial Intelligence, Health Tech, Hospitals, Providers
UNC Health CMIO: Clinicians and AI Must ‘Synergistically Work Together’
AI is meant to have a synergistic relationship with clinicians rather than replace them, pointed out David McSwain, chief medical information officer at UNC Health, during an interview at HIMSS24. In his view, both humans and AI are fallible, but their errors are usually of a different type — so both should be working together to reduce the overall error rate.
-
Artificial Intelligence, Health Tech, Hospitals, Providers
There’s a Crucial Part of Tech Pilot Design That Many Health Systems Forget, Geisinger Exec Says
During an interview this month at HIMSS24, David Vawdrey — Geisinger’s chief data and informatics officer — said health systems should spend more time designing their plan for evaluating success when it comes to tech pilots.
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Pharma, Artificial Intelligence, BioPharma
Survey: Pharma Commercial Teams Want More Data Analytics Solutions
Lack of automation is the top challenge facing commercialization teams, according to a survey of executives at U.S.-based pharma companies. The survey was conducted in late 2023 and results were reported this month.
-
Artificial Intelligence, Health Tech, Hospitals, Providers, SYN
Mount Sinai CEO: Hospitals Will Start Seeing ROI from Their AI Investments in a Couple Years
Health systems aren’t seeing a ton of ROI when it comes to their AI investments quite yet, as use of the technology is still in an iterative stage. However, Mount Sinai CEO Brendan Carr thinks that is likely to change in the next couple years.
-
Artificial Intelligence, BioPharma
AI Biotech Exscientia Fires CEO Hopkins for Relationships With Two Employees
Exscientia’s termination of CEO Andrew Hopkins is for cause and effective immediately. Grounds for termination include misconduct or behavior that brings Hopkins or the company into disrepute, according to his employment agreement.
-
Modern KOL Connections: Engaging with Thought Leaders in the Age of AI
AI refines KOL (key opinion leader) outreach by quickly uncovering the intricate details of individual thought leaders. AI tools can analyze preferences, behaviors, and interests, equipping MSLs (medical science liaisons) with a comprehensive understanding of each individual KOL.
-
Preparing Your Organization for AI in 2024: 10 Essential Elements of an Enterprise-Wide Strategy
When it comes to AI, the consensus is that healthcare organizations have an opportunity right now to take an enterprise-wide approach that encompasses everything from workforce to infrastructure to governance and beyond. Here are these ten essential elements of an enterprise-wide AI strategy for healthcare organizations.
-
How Can AI Support Value-Based Care?
During a panel discussion at CES 2024, health executives shared safe ways AI can be used to support value-based care. This includes automating tasks and predicting who needs additional care.
-
MedCity Influencers, Health Tech
5 Healthcare Trends that Will Shape 2024
As we look into the future, 2024 promises a profound transformation. Here are five areas of focus for the upcoming year.
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
Goldman Sachs Closes $650M Fund to Invest in ‘Golden Era’ of Biotech Innovation
Goldman Sachs’s new fund—its first dedicated to life sciences—will focus on early- to mid-stage therapeutics companies with multiple assets. Genetic medicine, cell therapy, immunotherapy, and artificial intelligence are among the areas of investment interest for the firm.
-
MedCity Influencers, Devices & Diagnostics
Unveiling the Future of Radiology: Key Trends from RSNA 2023
At RSNA, three major trends stood out: the integration of artificial intelligence (AI), a renewed focus on health equity, and a dedicated effort to enhance the patient experience.
-
How Are AI Companies Reacting to HHS’ New Transparency Requirements?
Last week, HHS finalized a new rule that requires healthcare AI developers to provide more data about their products to customers, which could aid providers in determining AI tools’ risks and effectiveness. Some AI leaders believe the new guardrails are a step in the right direction, and others are skeptical about whether the new rules are necessary or will be effective.
-
Pharma, Artificial Intelligence, BioPharma
AI-Generated Drug Candidates Are Here, But Clinical Trial Wins Need More Time
Despite artificial intelligence’s growing role in drug research, a fully AI-generated molecule has yet to advance from discovery all the way through clinical development. A novel molecule may eventually meet that goal, but some industry observers say it’s too early to focus on winning a race that has many twists and turns yet to come.
-
AI Enhances Workflows; It Doesn’t Replace Physicians.
The integration of AI into cardiology workflows can help triage care automatically, ensuring the right physicians weigh in on patient data at the right time which may potentially improve clinical outcomes for all patients in need.
-
MedCity Influencers, Artificial Intelligence
Paving the Way to Trust in Healthcare AI
Through rigorous validation processes, unwavering transparency, gradual implementation, and a steadfast commitment to preserving the human touch, healthcare IT providers can unequivocally demonstrate that AI is a reliable and trustworthy ally in the intricate and evolving landscape of healthcare.